AVEN Antikörper (C-Term)
(3 Referenzen)-
- Target Alle AVEN Antikörper anzeigen
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AVEN Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of AVEN.
- Kreuzreaktivität
- Human, Maus, Ratte
- Immunogen
- A synthetic peptide corresponding to C-terminus of human AVEN.
- Top Product
- Discover our top product AVEN Primärantikörper
-
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (AA 71-170) antibody
AVEN Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2B10 unconjugated
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (C-Term) antibodyAVEN Reaktivität: Human WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (AA 78-106), (N-Term) antibodyAVEN Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41905 unconjugated
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (C-Term) antibodyAVEN Reaktivität: Human, Affe WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (C-Term) antibodyAVEN Reaktivität: Human, Affe WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (C-Term) antibodyAVEN Reaktivität: Human, Maus, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (N-Term) antibodyAVEN Reaktivität: Human, Maus, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot (0.5-1 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C for three months. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Survivin and aven: two distinct antiapoptotic signals in acute leukemias." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 14, Issue 7, pp. 1045-50, (2003) (PubMed).
: "Cell death in the third millennium." in: Cell death and differentiation, Vol. 7, Issue 1, pp. 2-7, (2000) (PubMed).
: "Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1." in: Molecular cell, Vol. 6, Issue 1, pp. 31-40, (2000) (PubMed).
-
: "Survivin and aven: two distinct antiapoptotic signals in acute leukemias." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 14, Issue 7, pp. 1045-50, (2003) (PubMed).
-
- Target
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Andere Bezeichnung
- AVEN (AVEN Produkte)
- Synonyme
- AVEN antikoerper, pdcd12 antikoerper, aven antikoerper, wu:fc08c09 antikoerper, si:ch211-150c22.4 antikoerper, PDCD12 antikoerper, 1700013A01Rik antikoerper, 1700056A21Rik antikoerper, mAven-L antikoerper, mAven-S antikoerper, apoptosis and caspase activation inhibitor antikoerper, apoptosis, caspase activation inhibitor L homeolog antikoerper, apoptosis, caspase activation inhibitor antikoerper, Aven antikoerper, AVEN antikoerper, aven.L antikoerper, aven antikoerper
- Gen-ID
- 57099
-
